Cas:27825-22-5 3-bromo-pyrazine-2-carboxylic acid amide manufacturer & supplier

We serve Chemical Name:3-bromo-pyrazine-2-carboxylic acid amide CAS:27825-22-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-bromo-pyrazine-2-carboxylic acid amide

Chemical Name:3-bromo-pyrazine-2-carboxylic acid amide
CAS.NO:27825-22-5
Synonyms:3-Bromo-pyrazine-2-carboxylic acid amide;3-Brom-2-carbamoyl-pyrazin
Molecular Formula:C5H4BrN3O
Molecular Weight:202.00900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:68.87000
Exact Mass:200.95400
LogP:1.03830

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Bromo-pyrazine-2-carboxylic acid amide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Brom-2-carbamoyl-pyrazin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Bromo-pyrazine-2-carboxylic acid amide Use and application,3-Brom-2-carbamoyl-pyrazin technical grade,usp/ep/jp grade.


Related News: The continued momentum follows other major milestones and announcements from this year, including a $125 million Series D raise, $1.73 billion valuation, and key leadership team additions such as Prince Harry, The Duke of Sussex, as the company’s Chief Impact Officer. 2-[hydroxy(phenyl)phosphoryl]-2-phenylacetic acid manufacturers With over 80 years of experience developing and manufacturing small molecules, UQUIFA has not only the knowledge and tools to successfully execute transfer activities but also the track record of success with several crucial drug commercialization,” Gurnurkar says. N-[2-[4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]methyl]-1-piperidinyl]ethyl]-2-(methylamino)benzamide suppliers The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. 5-hydroxy-1,2:3,4-di-O-isopropylidenenonane vendor & factory.